Compare EnBio Holdings, Inc. with Similar Stocks
Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 10.11% over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 10.11% over the last 5 years
3
With ROCE of 7.29%, it has a fair valuation with a 0.81 Enterprise value to Capital Employed
4
Underperformed the market in the last 1 year
Stock DNA
Miscellaneous
JPY 5,870 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.72
2.68%
0.63
Revenue and Profits:
Net Sales:
3,528 Million
(Quarterly Results - Mar 2026)
Net Profit:
323 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.31%
0%
-15.31%
6 Months
11.67%
0%
11.67%
1 Year
12.38%
0%
12.38%
2 Years
9.43%
0%
9.43%
3 Years
8.92%
0%
8.92%
4 Years
29.2%
0%
29.2%
5 Years
14.94%
0%
14.94%
EnBio Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.11%
EBIT Growth (5y)
18.23%
EBIT to Interest (avg)
8.62
Debt to EBITDA (avg)
3.90
Net Debt to Equity (avg)
0.74
Sales to Capital Employed (avg)
0.55
Tax Ratio
72.46%
Dividend Payout Ratio
27.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.48%
ROE (avg)
8.89%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.67
EV to EBIT
11.15
EV to EBITDA
7.52
EV to Capital Employed
0.81
EV to Sales
1.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.29%
ROE (Latest)
-2.47%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
3,528.00
3,419.00
3.19%
Operating Profit (PBDIT) excl Other Income
648.00
595.00
8.91%
Interest
49.00
43.00
13.95%
Exceptional Items
0.00
2.00
-100.00%
Consolidate Net Profit
323.00
-611.00
152.86%
Operating Profit Margin (Excl OI)
143.70%
133.10%
1.06%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 3.19% vs 5.36% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 152.86% vs -214.42% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
12,630.00
10,668.10
18.39%
Operating Profit (PBDIT) excl Other Income
2,162.00
1,346.10
60.61%
Interest
179.00
141.30
26.68%
Exceptional Items
5.00
17.20
-70.93%
Consolidate Net Profit
252.00
420.20
-40.03%
Operating Profit Margin (Excl OI)
128.20%
79.50%
4.87%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 18.39% vs 11.41% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -40.03% vs -43.19% in Mar 2025
About EnBio Holdings, Inc. 
EnBio Holdings, Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available






